Breathe Well Live Well
Lung Disease News |
Breo Ellipta Now Approved as Asthma Treatment for Adult Patients in Canada
Lung Disease News GlaxoSmithKline (GSK) and VIBATIV® (telavancin) developer Theravance Biopharma, have just been granted Canadian approval for Breo Ellipta, a once-a-day maintenance treatment for asthma in patients who are at least 18 years old and have reversible … |
View full post on asthma – Google News
Lung Disease News |
Tiotropium Therapy Shown As Safe and Effective Treatment for Adolescents with …
Lung Disease News Asthma is a common chronic inflammatory lung disease characterized by airflow obstruction that causes wheezing, shortness of breath, chest tightness and coughing. The respiratory disorder is estimated to affect 27 million individuals in the United States. |
View full post on asthma – Google News
Lung Disease News |
New Observations Made in Asthma-COPD Overlap Syndrome (ACOS) Patients
Lung Disease News Asthma-COPD overlap syndrome (ACOS) accounts for 15 to 25% of obstructive airway diseases and patients affected with ACOS usually exhibit worse symptoms and clinical outcomes when compared to patients with asthma or chronic obstructive pulmonary … |
View full post on asthma – Google News
Lung Disease News |
On-Chip Processor An Advance in Point-of-Care Asthma and Tuberculosis Diagnostics
Lung Disease News Asthma pathogenesis of involves airway inflammation, airway remodeling, and hyperreactivity, which lead to difficulty in breathing that can be deadly if not properly controlled. Steroid medications can successfully treat asthma in most cases, but side … Lab on a Chip Acoustofluidic Sputum Liquefaction Device for Safe Asthma and … New Lab-on-a-Chip to identify Asthma as well as Tuberculosis On-Chip Processor the First Step in Point-of-Care Tuberculosis and Asthma … |
View full post on asthma – Google News
Lung Disease News |
Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma
Lung Disease News Australia-based pharmaceutical company Invion Ltd. recently signed a partnership agreement with Hovione Scientia Ltd., a multinational pharmaceutical company focused on developing inhaled therapeutics, for the advancement of INV104 (zafirlukast) as a … |
View full post on asthma – Google News
|
Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma Lung …
Lung Disease News GSK Expands Its COPD And Asthma Portfolio Across The US. Australia-based pharmaceutical company Invion Ltd. recently signed a partnership agreement with Hovione Scientia Ltd., a multinational pharmaceutical company focused on developing inhaled … |
View full post on asthma – Google News
Lung Disease News |
Airway Resistance Measurements Shown to Help Effectively Differentiate …
Lung Disease News To examine the contribution of RAW and sGAW to a diagnosis of obstructive airways disease and their role in differentiating asthma from COPD, in the study titled “Airways resistance and specific conductance for the diagnosis of obstructive airways … |
View full post on asthma – Google News
Lung Disease News |
AstraZeneca Signs Partnership With Kyowa Hakko Kirin To Commercialize Asthma …
Lung Disease News It will also retain responsibility for furthering the drug's research and development in Japan, and keep hold of rights to participate in some of AstraZeneca's commercial activities. AstraZeneca will be accountable for all sales and marketing in asthma … |
View full post on asthma – Google News
Lung Disease News |
AstraZeneca Signs Partnership With Kyowa Hakko Kirin To Commercialize …
Lung Disease News It will also retain responsibility for furthering the drug's research and development in Japan, and keep hold of rights to participate in some of AstraZeneca's commercial activities. AstraZeneca will be accountable for all sales and marketing in asthma … |
View full post on asthma – Google News
Lung Disease News |
Chicago-based Clinical Trial Exploring Coordinated Healthcare Interventions …
Lung Disease News In Chicago, the rates of asthma in children are remarkably high, and the condition has been found to have a high incidence among African-American children. The CHICAGO trial (Coordinated Healthcare Interventions for Childhood Asthma Gaps in … |
View full post on asthma – Google News